Prognostic significance of gamma-glutamyltransferase in patients with endometrial cancer: a multi-centre trial

Case-Control Study of the Metabolic Syndrome and Metabolic Risk Factors for Endometrial Cancer

(2011) C. M. Friedenreich et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Gamma-glutamyltransferase and risk of cancer in a cohort of 545,460 persons – the Swedish AMORIS study

(2011) Mieke Van Hemelrijck et al.   EUROPEAN JOURNAL OF CANCER

Relevance of gamma-glutamyltransferase – a marker for apoptotic balance – in predicting tumor stage and prognosis in cervical cancer

(2011) Stephan Polterauer et al.   GYNECOLOGIC ONCOLOGY

Obesity in relation to endometrial cancer risk and disease characteristics in the Women's Health Initiative

(2011) Katherine W. Reeves et al.   GYNECOLOGIC ONCOLOGY

The prognostic value of plasma fibrinogen levels in patients with endometrial cancer: a multi-centre trial

(2010) V Seebacher et al.   BRITISH JOURNAL OF CANCER

Redox regulation of the tumor suppressor PTEN by glutathione

(2010) Yujeong Kim et al.   FEBS LETTERS

Association of  -Glutamyltransferase and Risk of Cancer Incidence in Men: A Prospective Study

(2008) A. M. Strasak et al.   CANCER RESEARCH

Elevated Serum Alanine Aminotransferase and γ-Glutamyltransferase and Mortality in the United States Population

(2008) Constance E. Ruhl et al.   GASTROENTEROLOGY

Prospective study of the association of gamma-glutamyltransferase with cancer incidence in women

(2008) Alexander M. Strasak et al.   INTERNATIONAL JOURNAL OF CANCER